Fenbendazole and Ivermectin for Esophageal and Stomach (Gastric) Cancer Success Stories: 12 Case Reports Compilation (December 2025)
In the relentless battle against gastrointestinal cancers, esophageal and gastric tumors stand as formidable adversaries, often diagnosed at advanced stages with grim prognoses that leave patients facing palliative care rather than cures. Conventional therapies—chemotherapy, immunotherapy, and radiation—can extend life but frequently exact a heavy toll, prompting many to seek alternatives beyond the standard arsenal. Amid this landscape of desperation and innovation emerges a surprising duo: fenbendazole and ivermectin, antiparasitic agents repurposed from veterinary use that have shown intriguing anticancer properties in preclinical studies and, now, in human anecdotes. This compilation unveils 11 extraordinary case reports, spanning from hospice-bound elders to vigorous mid-lifers, where these drugs, often combined with minimal supplements or alongside traditional treatments, yielded remissions, tumor shrinkage, and restored quality of life—challenging the boundaries of what's p...